CorDx, Inc.
Explore this company’s associated devices, FDA decisions and regulatory history.

CorDx, Inc.
- Regulatory records
- 2
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 2 FDA records to the applicant name CorDx, Inc.. The collection includes 2 510(k) clearances. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Jun 1, 2026 to Oct 14, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code QVF appears in 1 of the 2 linked filings. The collection spans 2 FDA product codes. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 5900 Windward Pkwy., Alpharetta, GA, 30005, US. Recorded on K262432, decision dated Oct 14, 2026.
Device categories in this collection
Multi-Analyte Respiratory Virus Antigen Detection Test; Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Regulatory record history
CorDx Tyfast Flu A/B & COVID-19 At Home Multiplex Rapid Test; CorDx Tyfast Flu A/B & COVID-19 Multiplex Rapid Test
K262432 · 510(k) clearanceCorDx Tyfast COVID-19 Ag Rapid Test Rx
K253882 · 510(k) clearance
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.